Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model.

Napimoga MH, da Silva CA, Carregaro V, Farnesi-de-Assunção TS, Duarte PM, de Melo NF, Fraceto LF.

J Immunol. 2012 Jul 15;189(2):1043-52. doi: 10.4049/jimmunol.1200730. Epub 2012 Jun 15.

2.

Effects of 15d-PGJ₂-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation.

Alves C, de Melo N, Fraceto L, de Araújo D, Napimoga M.

Br J Pharmacol. 2011 Feb;162(3):623-32. doi: 10.1111/j.1476-5381.2010.01057.x.

3.

15d-PGJ2-loaded in nanocapsules enhance the antinociceptive properties into rat temporomandibular hypernociception.

Clemente-Napimoga JT, Moreira JA, Grillo R, de Melo NF, Fraceto LF, Napimoga MH.

Life Sci. 2012 Jun 14;90(23-24):944-9. doi: 10.1016/j.lfs.2012.04.035. Epub 2012 Apr 27.

4.

The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.

Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.

Life Sci. 2009 Jul 3;85(1-2):46-53. doi: 10.1016/j.lfs.2009.04.010. Epub 2009 May 3.

PMID:
19409914
5.

[Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity].

Yuan ZY, Liu Y, Liu Y, Zhang JJ, Kishimoto C, Liu ZQ.

Zhonghua Yi Xue Za Zhi. 2003 Dec 10;83(23):2067-72. Chinese.

PMID:
14703419
6.

Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.

Koyama M, Izutani Y, Goda AE, Matsui TA, Horinaka M, Tomosugi M, Fujiwara J, Nakamura Y, Wakada M, Yogosawa S, Sowa Y, Sakai T.

Clin Cancer Res. 2010 Apr 15;16(8):2320-32. doi: 10.1158/1078-0432.CCR-09-2301. Epub 2010 Apr 6.

7.

The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation.

Cuzzocrea S, Wayman NS, Mazzon E, Dugo L, Di Paola R, Serraino I, Britti D, Chatterjee PK, Caputi AP, Thiemermann C.

Mol Pharmacol. 2002 May;61(5):997-1007.

8.

Effect of 15-Deoxy-Δ12,14-prostaglandin J2Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model.

Tang Q, Chen LL, Wei F, Sun WL, Lei LH, Ding PH, Tan JY, Chen XT, Wu YM.

Chin Med J (Engl). 2017 Feb 5;130(3):347-356. doi: 10.4103/0366-6999.198924.

9.

The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.

Cuzzocrea S, Ianaro A, Wayman NS, Mazzon E, Pisano B, Dugo L, Serraino I, Di Paola R, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.

Br J Pharmacol. 2003 Feb;138(4):678-88.

10.

15d-PGJ(2) modulates acute immune responses to Trypanosoma cruzi infection.

Rodrigues WF, Miguel CB, Chica JE, Napimoga MH.

Mem Inst Oswaldo Cruz. 2010 Mar;105(2):137-43.

11.

Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.

Pena-dos-Santos DR, Severino FP, Pereira SA, Rodrigues DB, Cunha FQ, Vieira SM, Napimoga MH, Clemente-Napimoga JT.

Neuroscience. 2009 Nov 10;163(4):1211-9. doi: 10.1016/j.neuroscience.2009.07.052. Epub 2009 Jul 30.

PMID:
19647045
12.

15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.

Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY, Park JI.

Clin Cancer Res. 2009 Sep 1;15(17):5414-25. doi: 10.1158/1078-0432.CCR-08-3101. Epub 2009 Aug 18.

13.
14.

The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection.

Cloutier A, Marois I, Cloutier D, Verreault C, Cantin AM, Richter MV.

J Infect Dis. 2012 Feb 15;205(4):621-30. doi: 10.1093/infdis/jir804. Epub 2012 Jan 4.

PMID:
22219346
15.

15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.

Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri WA Jr, Cunha FQ, Ferreira SH.

J Pharmacol Exp Ther. 2008 Jan;324(1):313-21. Epub 2007 Oct 10.

16.

Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.

Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D.

Mol Pharmacol. 2004 Nov;66(5):1349-58. Epub 2004 Aug 18.

17.

Generation of monoclonal antibody for 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ and development of enzyme-linked immunosorbent assay for its quantification in culture medium of adipocytes.

Syeda PK, Hossain MS, Chowdhury AA, Rahman MS, Nishimura K, Jisaka M, Nagaya T, Shono F, Yokota K.

Appl Biochem Biotechnol. 2012 Jul;167(5):1107-18. doi: 10.1007/s12010-012-9616-9. Epub 2012 Mar 7.

PMID:
22391692
18.

15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.

Katura T, Moriya T, Nakahata N.

Mol Pharmacol. 2010 Apr;77(4):601-11. doi: 10.1124/mol.109.061010. Epub 2010 Jan 19.

19.
20.

15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.

Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N.

Ther Apher Dial. 2010 Feb;14(1):43-51. doi: 10.1111/j.1744-9987.2009.00702.x.

PMID:
20438519

Supplemental Content

Support Center